HROW has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HROW has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Harrow's change in receivables for the quarter that ended in Mar. 2024 was $8.4 Mil. It means Harrow's Accounts Receivable declined by $8.4 Mil from Dec. 2023 to Mar. 2024 .
Harrow's change in receivables for the fiscal year that ended in Dec. 2023 was $-30.3 Mil. It means Harrow's Accounts Receivable increased by $30.3 Mil from Dec. 2022 to Dec. 2023 .
Harrow's Accounts Receivable for the quarter that ended in Mar. 2024 was $29.0 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Harrow's Days Sales Outstanding for the three months ended in Mar. 2024 was 76.40.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Harrow's liquidation value for the three months ended in Mar. 2024 was $-132.2 Mil.
The historical data trend for Harrow's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harrow Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | -0.10 | -0.87 | -1.83 | -1.86 | -30.34 |
Harrow Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Change In Receivables | Get a 7-Day Free Trial | -5.88 | -6.16 | -0.25 | -18.06 | 8.40 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harrow (NAS:HROW) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Harrow's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 28.96 | / | 34.587 | * | 91 |
= | 76.40 |
2. In Ben Graham's calculation of liquidation value, Harrow's accounts receivable are only considered to be worth 75% of book value:
Harrow's liquidation value for the quarter that ended in Mar. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 75.971 | - | 235.33 | + | 0.75 * 28.96 | + | 0.5 * 10.81 |
= | -132.2 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Harrow's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Mark L Baum | director, 10 percent owner, officer: Chief Executive Officer | C/O IMPRIMIS PHARMACEUTICALS, INC, 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130 |
Opaleye Management Inc. | 10 percent owner | ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108 |
Martin A. Makary | director | 102 WOODMONT BLVD., SUITE 610, NASHVILLE TN 37205 |
Van Horn R. Lawrence | director | 354 COOL SPRINGS BLVD., SUITE 106, FRANKLIN TN 37067 |
Andrew Boll | officer: VP, Accounting and Reporting | 437 S HWY 101, STE 209, SOLANA BEACH CA 92075 |
Lindstrom Richard L Md | director | 2811 WESTWOOD PL, WAYZATA MN 55391 |
Perry J. Sternberg | director | 102 WOODMONT BLVD., SUITE 610, NASHVILLE TN 37205 |
Teresa Sparks | director | 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215 |
Robert J Kammer | director, 10 percent owner, officer: Chairman of the Board | 1440 28TH STREET, SUITE 9, BOULDER CO 80303 |
Longboard Capital Advisors, Llc | other: Institutional Investor | 9665 WILSHIRE BLVD., SUITE 430, BEVERLY HILLS CA 90212 |
Brett Conrad | other: Managing Mbr of Longboard Cap. | 1312 CEDAR ST., SANTA MONICA CA 90405 |
Clayton D Edwards | officer: Chief Operating Officer | 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130 |
Anthony Principi | director | 2300 WEST PLANO PARKWAY, M/S D2420, PLANO TX 75244 |
Donald Paul Miloni | 10 percent owner | 1425 GREENWOOD LANE, GREENWOOD VILLAGE CO 80125 |
John P. Saharek | officer: Chief Commercial Officer | 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130 |
From GuruFocus
By Business Wire • 11-29-2023
By Business Wire • 09-26-2023
By Business Wire • 08-09-2023
By Business Wire • 10-24-2023
By GuruFocus Research • 11-17-2023
By GuruFocus Research • 09-21-2023
By Business Wire • 07-18-2023
By Business Wire • 01-03-2024
By Business Wire • 07-18-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.